Physician profile
G Franklin
NPI 1780618843
$2,403.04
in general payments reported to CMS, 2019-2025
15 companies · $1,506 in 2025
The $1,506 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.11 · 2020: $116 · 2021: $48.11 · 2022: $107 · 2023: $188 · 2024: $341 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,936.86 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $800.08 | 2023-2025 | |
| Inspire Medical Systems, INC. | $418.26 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $215.69 | 2020-2024 | Dupixent |
| Acclarent, INC | $155.47 | 2019-2021 | |
| Abbvie INC. | $146.35 | 2025 | |
| Amgen INC. | $135.95 | 2025 | Repatha |
| Medtronic, INC. | $135.94 | 2024-2025 | Propel, Novapak |
| Integra Lifesciences Corporation | $119.41 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Genzyme Corporation | $91.45 | 2022-2024 | |
| Stryker Corporation | $54.21 | 2019-2025 | Scopis Ent |
| Glaxosmithkline, LLC. | $38.49 | 2022 | |
| Cochlear Americas | $33.62 | 2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Allergan, INC. | $32.31 | 2022 | |
| Olympus America INC. | $14.00 | 2021 | |
| Optinose US, INC. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw G Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.